Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 32.20
-0.10 (-0.31%)
Dec 5, 2025, 1:30 PM CST
Synmosa Biopharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1,108 | 1,186 | 918.56 | 1,088 | 868.17 | 638.35 | Upgrade
|
| Short-Term Investments | 388.27 | 120.31 | 520 | 310 | 115 | 100 | Upgrade
|
| Trading Asset Securities | 705.1 | 575.94 | 211.45 | 20.1 | 5.26 | 7.01 | Upgrade
|
| Cash & Short-Term Investments | 2,202 | 1,882 | 1,650 | 1,418 | 988.43 | 745.35 | Upgrade
|
| Cash Growth | 23.79% | 14.08% | 16.38% | 43.43% | 32.61% | 30.74% | Upgrade
|
| Accounts Receivable | 1,341 | 1,252 | 1,155 | 1,125 | 799.64 | 702.53 | Upgrade
|
| Other Receivables | 89.96 | 57.88 | 48.43 | 20.86 | 10.47 | 16.31 | Upgrade
|
| Receivables | 1,431 | 1,310 | 1,203 | 1,146 | 810.11 | 718.84 | Upgrade
|
| Inventory | 2,163 | 1,787 | 1,651 | 1,384 | 1,214 | 1,239 | Upgrade
|
| Prepaid Expenses | 60.75 | 34.54 | 28.1 | - | 51.11 | 47.23 | Upgrade
|
| Other Current Assets | 1.77 | 5.31 | 7 | 60.84 | 35.05 | 231.46 | Upgrade
|
| Total Current Assets | 5,858 | 5,019 | 4,539 | 4,008 | 3,099 | 2,982 | Upgrade
|
| Property, Plant & Equipment | 5,453 | 5,589 | 5,557 | 5,638 | 5,662 | 5,788 | Upgrade
|
| Long-Term Investments | 345.52 | 336.48 | 222.87 | 223.01 | 303.48 | 271.52 | Upgrade
|
| Goodwill | 62.29 | 62.29 | 62.29 | 71.08 | 7.27 | 13.27 | Upgrade
|
| Other Intangible Assets | 394.1 | 449.22 | 496.56 | 496.8 | 494.03 | 536.69 | Upgrade
|
| Long-Term Deferred Tax Assets | 388.46 | 363.27 | 330.56 | 331.78 | 329.28 | 311.7 | Upgrade
|
| Other Long-Term Assets | 1,570 | 484.54 | 519.9 | 433.53 | 421.53 | 473.71 | Upgrade
|
| Total Assets | 14,072 | 12,304 | 11,729 | 11,203 | 10,317 | 10,377 | Upgrade
|
| Accounts Payable | 566.22 | 471.02 | 427.54 | 446.16 | 249.58 | 184.26 | Upgrade
|
| Accrued Expenses | 466.66 | 443.36 | 381.68 | 368.47 | 264.64 | 260.62 | Upgrade
|
| Short-Term Debt | 917 | 674.89 | 661.22 | 584.08 | 763.77 | 630.76 | Upgrade
|
| Current Portion of Long-Term Debt | 178.48 | 72.33 | 289.39 | 584.42 | 413.9 | 256.53 | Upgrade
|
| Current Portion of Leases | 27.54 | 22.94 | 23.3 | 16.7 | 6.74 | 6.83 | Upgrade
|
| Current Income Taxes Payable | 72.44 | 142.57 | 118.29 | 95.54 | 53.18 | 54.61 | Upgrade
|
| Current Unearned Revenue | 114.66 | 163.72 | 172.29 | 173.43 | 126.87 | 129.31 | Upgrade
|
| Other Current Liabilities | 46.89 | 83.76 | 44.71 | 53.91 | 10.21 | 36.74 | Upgrade
|
| Total Current Liabilities | 2,390 | 2,075 | 2,118 | 2,323 | 1,889 | 1,560 | Upgrade
|
| Long-Term Debt | 1,643 | 1,729 | 1,400 | 2,122 | 2,272 | 2,804 | Upgrade
|
| Long-Term Leases | 41.92 | 49.86 | 58.66 | 48.42 | 6.76 | 3.84 | Upgrade
|
| Long-Term Unearned Revenue | 8.84 | 5.53 | 2.35 | - | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 6.24 | 7.8 | 12.24 | 13.89 | 19.18 | 19.79 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 32.6 | 37.42 | 35.45 | 34.52 | 34.2 | 35.11 | Upgrade
|
| Other Long-Term Liabilities | 1.26 | 1.26 | 0.53 | 12.62 | 0.89 | 0.86 | Upgrade
|
| Total Liabilities | 4,124 | 3,905 | 3,628 | 4,554 | 4,221 | 4,423 | Upgrade
|
| Common Stock | 5,102 | 4,293 | 4,014 | 3,437 | 3,131 | 2,808 | Upgrade
|
| Additional Paid-In Capital | 2,695 | 2,082 | 2,195 | 1,425 | 1,426 | 1,403 | Upgrade
|
| Retained Earnings | 1,090 | 1,096 | 1,092 | 1,005 | 613.43 | 713.49 | Upgrade
|
| Treasury Stock | -187.73 | -205.68 | -486.96 | -486.96 | -402.62 | -350.87 | Upgrade
|
| Comprehensive Income & Other | -44.13 | -55.82 | -104.78 | -68.18 | -63.04 | -73.45 | Upgrade
|
| Total Common Equity | 8,654 | 7,210 | 6,710 | 5,312 | 4,706 | 4,500 | Upgrade
|
| Minority Interest | 1,294 | 1,189 | 1,391 | 1,337 | 1,390 | 1,455 | Upgrade
|
| Shareholders' Equity | 9,949 | 8,399 | 8,101 | 6,649 | 6,095 | 5,955 | Upgrade
|
| Total Liabilities & Equity | 14,072 | 12,304 | 11,729 | 11,203 | 10,317 | 10,377 | Upgrade
|
| Total Debt | 2,808 | 2,549 | 2,433 | 3,355 | 3,463 | 3,702 | Upgrade
|
| Net Cash (Debt) | -605.94 | -666.47 | -782.59 | -1,937 | -2,474 | -2,956 | Upgrade
|
| Net Cash Per Share | -1.24 | -1.44 | -1.75 | -4.49 | -5.69 | -6.96 | Upgrade
|
| Filing Date Shares Outstanding | 501.47 | 462.21 | 462.21 | 429.15 | 432.91 | 436.18 | Upgrade
|
| Total Common Shares Outstanding | 501.47 | 462.21 | 462.21 | 429.15 | 432.91 | 436.18 | Upgrade
|
| Working Capital | 3,468 | 2,945 | 2,421 | 1,686 | 1,210 | 1,423 | Upgrade
|
| Book Value Per Share | 17.26 | 15.60 | 14.52 | 12.38 | 10.87 | 10.32 | Upgrade
|
| Tangible Book Value | 8,198 | 6,699 | 6,151 | 4,744 | 4,204 | 3,950 | Upgrade
|
| Tangible Book Value Per Share | 16.35 | 14.49 | 13.31 | 11.05 | 9.71 | 9.06 | Upgrade
|
| Land | 3,392 | 3,528 | 3,528 | 3,558 | 3,558 | 3,567 | Upgrade
|
| Buildings | 1,605 | 1,587 | 1,567 | 1,558 | 1,542 | 1,561 | Upgrade
|
| Machinery | 2,249 | 2,050 | 1,893 | 1,790 | 1,696 | 1,728 | Upgrade
|
| Construction In Progress | 26.72 | 89.55 | 19.08 | 9.74 | 62.51 | 47.32 | Upgrade
|
| Leasehold Improvements | 83.51 | 83.19 | 80.49 | 78.96 | 22.62 | 19.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.